Colorectal cancer is the third most common cancer in the United States, and in Maryland alone, colon cancer is the second leading cause of cancer deaths. If detected early, colorectal cancer can often be successfully treated or event prevented.
The Colon Cancer Center is a multidisciplinary program, which provides comprehensive consultation, screening, diagnostic, surveillance and prevention, and the latest treatment services for patients with cancer of the large bowel and those at risk of developing cancer of the colon and rectum.
Swim Across America Laboratory
Swim Across America, Inc., an organization of volunteer swimmers and friends and family members of cancer patients that raises money for cancer research through swim events, has funded a laboratory at the Johns Hopkins Kimmel Cancer Center headed by oncologist Luis Diaz, M.D. A ribbon-cutting ceremony was held on June 20, 2011.
Colon Cancer Patients Couples Retreat
The couples retreat is for patients living with metastatic colorectal cancer and their partners and provide an opportunity to share and network with others facing the same challanges. It is designed to ease psychological distress for the patient and the spouse and faciilitate interactions in an environment that is comfortable and conducive to open frank discussions about emotional impact of metastatic colorectal cancer on the patient, spouse and other family members.
The program is offered at no cost to the patient and their partner. Space is limited. For more information please contact Eden Stotsky-Himelfarb, BSN, RN., at 410-502-3098 or email@example.com.
- Age 50 or older
- Family history of colon cancer or polyps*
- Use tobacco or alcohol*
- African American or Eastern European descent*
*At even higher risk
About two thirds of colon cancer patients have localized colon cancer which is best treated surgically. At Johns Hopkins, colon cancer patients benefit from having surgeons who specialize in treating colorectal cancers as well as team of multidisciplinary professionals reviewing and managing patient care including tumor analysis and disease staging. Outcomes for stage I and II colon cancer are very good at a 95 percent cure rate.